TABLE 3.

Examples of recent clinical trials for antibiotics against MRSA

Drug	NCT number	Phase	Status
CG400549	NCT01593761	Phase II	Completed
CG400549	NCT01593761	Phase II	Completed
Delafloxacin	NCT01811732, NCT01984684	Phase III	Completed
Iclaprim	NCT02600611, NCT02607618	Phase III	Completed
Lefamulin	NCT01119105, NCT02559310, NCT02813694	Phase II/III	Completed
LTX-109	NCT01158235	Phase I/II	Completed
MRX-1	NCT02269319	Phase II	Completed
Nemonoxacin	NCT01944774, NCT00685698	Phase II	Completed
Retapamulin	NCT03304873	Phase III	Completed
XF-73	NCT03915470	Phase II	Recruiting